Tanaka Capital Management Inc Corcept Therapeutics Inc Transaction History
Tanaka Capital Management Inc
- $40.6 Million
- Q1 2024
A detailed history of Tanaka Capital Management Inc transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Tanaka Capital Management Inc holds 90,876 shares of CORT stock, worth $3.08 Million. This represents 5.63% of its overall portfolio holdings.
Number of Shares
90,876
Previous 37,091
145.01%
Holding current value
$3.08 Million
Previous $1.21 Million
89.96%
% of portfolio
5.63%
Previous 2.95%
Shares
20 transactions
Others Institutions Holding CORT
# of Institutions
318Shares Held
93.6MCall Options Held
2.02MPut Options Held
3.24M-
Black Rock Inc. New York, NY16.8MShares$570 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.57MShares$324 Million0.0% of portfolio
-
Ingalls & Snyder LLC New York, NY8.3MShares$281 Million9.24% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny7.12MShares$241 Million0.28% of portfolio
-
Parallel Advisors, LLC3.82MShares$129 Million2.62% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $3.63B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...